✦ LIBER ✦

Increases In Erythropoiesis Stimulating Agent (Esa) Use After Hospitalization Of End Stage Renal Disease (Esrd) Patients

✍ Scribed by T. Christopher Bond; Steven Wang; Jaime Rubin; Alex Yang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PUK29 Erythropoietin-Stimulating Agent (

✍ X. Wang; T.C. Bond; J.L. Rubin; A. Yang 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PUK7 Safety of Erythropoiesis-Stimulatin

✍ T. Cavanaugh; B. Bian; E.A. Berry; C.M. Kelton 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Fate of hypertension (HTN) before and af

✍ C. Venkata; S. Ram; Robert Toto; David Nesser; Lannette Harris; Patricia Lemons; 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 33 KB

A23 - Metabolites of nitric oxide are in

✍ D Diederich; J Skopec; A Diederich; F-X Dai 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

The use of B-type natriuretic peptide to

✍ Victoria Sheen; Vikas Bhalla; Alisi Tulua-Tata; Meenakshi A. Bhalla; Danielle We 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 44 KB

PUK14 A HEALTH ECONOMIC EVALUATION OF TH

✍ LA Van Bellinghen; M Lamotte; M Malfait 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB